RB1 and prostate carcinoma: Indeed, a higher frequency of RB1 mRNA downregulation was observed in recurrent prostate cancers from patients who had undergone combined androgen blockade with respect to cancers from untreated patients, suggesting that RB1 inactivation might be associated with hormone treatment resistance [107].